ドラッグデリバリーデバイスの世界市場：規模、シェア・動向分析レポート - 用途別、投与経路別、最終用途別、地域別、セグメント予測、2024～2030年

ドラッグデリバリーデバイス市場の成長と動向：

世界のドラッグデリバリーデバイスの市場規模は、予測期間中にCAGR 5.83%で成長し、2030年までに4,036億米ドルに達する見込みです。

がん、神経疾患、糖尿病、その他の感染症の有病率の増加が、今後数年間におけるドラッグデリバリーデバイスの採用を促進すると予想されています。また、眼科、神経学、腫瘍学など様々な用途向けの製品発売の増加も市場成長を促進すると見られています。また、在宅医療現場での使用を目的としたウェアラブル薬物送達デバイスの採用拡大も、市場を牽引すると予想されます。

ハイドロゲルは著名なドラッグデリバリービークルの一つであり、超分子ハイドロゲル、DNAハイドロゲル、バイオインスパイアードハイドロゲル、多機能ハイドロゲル、刺激応答性ハイドロゲルなどが含まれます。これらの高度なハイドロゲルは、眼科、経口、腸、心疾患、がんなど様々な用途に使用されています。同様に、リポソーム、ナノ粒子、ミセルなどの他のビークルも様々な用途向けに開発されています。

市場に存在する主な企業は、様々な用途のドラッグデリバリーデバイスを開発・改良するために、M&A、提携、共同研究など様々な戦略を採用しています。さらに、エンドユーザーも企業とパートナーシップを結び、トレーニング目的や調査研究のためにドラッグデリバリーデバイスを入手しています。さらに、市場プレーヤーは、自社製品のリーチを拡大するために販売代理店契約を結んでいます。したがって、各社による提携は予測期間中の市場成長を促進すると予想されます。

ドラッグデリバリーデバイス市場のレポートハイライト：

• 経口投与経路セグメントは、主にその容易な使用と低コストにより、2023年に最大のシェアを占めました。
• 予測期間中、注射剤投与ルートが最も急成長すると予測されるのは、主に精度を高めるための注射剤投与デバイスの進歩が進んでいるためです。
• 中枢神経系疾患用ドラッグデリバリーデバイスは、主に神経疾患治療用の血液脳関門型ドラッグデリバリーデバイスの開発が進んでいることから、予測期間中に急成長が見込まれます。
• 2023年、北米は、同地域でのドラッグデリバリーデバイスの採用と米国などの国々での製品発売の増加により、世界最大の収益シェアを占めました。
• アジア太平洋は、ドラッグデリバリーデバイスの開発と進歩が進んでおり、患者数が多いことから、予測期間中に最も速い成長率が見込まれています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ドラッグデリバリーデバイス市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 普及・成長の見通しマッピング
• 業界のバリューチェーン分析
  • 償還の枠組み
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 業界の課題
• ドラッグデリバリーデバイス市場分析ツール
  • 業界分析 - ポーターのファイブフォース分析
  • PESTEL分析
  • 主要取引と戦略的提携の分析
  • 市場参入戦略

第4章 投与経路（RoA）の推定・動向分析

• 定義と範囲
  • 経口
  • 吸入
  • 経皮
  • 注射剤
  • 眼
  • 経鼻
  • 局所
  • その他
• RoA市場シェア、2024・2030年
• セグメントダッシュボード
• 世界のドラッグデリバリーデバイス市場：RoA別見通し
• 以下の市場規模、予測・動向分析、2018～2030年
  • 経口
  • 吸入
  • 経皮
  • 注射剤
  • 眼
  • 経鼻
  • 局所
  • その他

第5章 用途の推定・動向分析

• 定義と範囲
  • 腫瘍学
  • 感染症
  • 呼吸器疾患
  • 糖尿病
  • 循環器疾患
  • 自己免疫疾患
  • 中枢神経系障害
  • その他
• 用途市場シェア、2024・2030年
• セグメントダッシュボード
• 世界のドラッグデリバリーデバイス市場：用途別見通し
• 以下の市場規模、予測・動向分析、2018～2030年
  • 腫瘍学
  • 感染症
  • 呼吸器疾患
  • 糖尿病
  • 心血管疾患
  • 自己免疫疾患
  • 中枢神経系障害
  • その他

第6章 最終用途の推定・動向分析

• 定義と範囲
  • 病院
  • 診断センター
  • 外来手術センター/クリニック
  • 在宅ケア設定
  • その他
• 最終用途市場シェア、2023・2030年
• セグメントダッシュボード
• 世界のドラッグデリバリーデバイス市場：最終用途別見通し
• 以下の市場規模、予測・動向分析、2018～2030年
  • 病院
  • 診断センター
  • 外来手術センター/クリニック
  • 在宅ケア設定
  • その他

第7章 ドラッグデリバリーデバイス市場：地域の推定・動向分析

• 地域市場シェア分析、2023・2030年
• 地域市場ダッシュボード
• 世界の地域市場のスナップショット
• 地域市場シェアと主要企業、2019年
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ
• SWOT分析、要因別（政治・法律、経済・技術）
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ
• 市場規模・予測、数量・動向分析、2018～2030年
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
  • イノベーター
  • 市場レンダー
  • 新興企業
• ベンダー情勢
  • List of key distributors and channel partners
  • Key customers
  • Key company market share analysis, 2023
• 公開企業
• 非公開企業
• サプライヤーランキング
• 主要企業プロファイル
  • Pfizer, Inc,
  • F. Hoffmann-La Roche Ltd.
  • Johnson and Johnson Services
  • Novartis AG
  • Bayer AG
  • BD
  • Uniqure N.V.
  • SiBiono GeneTech Co.
  • Shanghai Sunway Biotech Co., Ltd
  • Human Stem Cells Institute

List of Tables

• Table 1 List of Abbreviations
• Table 2 North America drug delivery devices market, by country, 2018 - 2030 (USD Billion)
• Table 3 North America drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 4 North America drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 5 North America drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 6 U.S. drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 7 U.S. drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 8 U.S. drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 9 Canada drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 10 Canada drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 11 Canada drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 12 Europe drug delivery devices market, by region, 2018 - 2030 (USD Billion)
• Table 13 Europe drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 14 Europe drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 15 Europe drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 16 Germany drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 17 Germany drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 18 Germany drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 19 U.K. drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 20 U.K. drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 21 U.K. drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 22 France drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 23 France drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 24 France drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 25 Italy drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 26 Italy drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 27 Italy drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 28 Spain drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 29 Spain drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 30 Spain drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 31 Denmark drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 32 Denmark drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 33 Denmark drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 34 Sweden drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 35 Sweden drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 36 Sweden drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 37 Norway drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 38 Norway drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 39 Norway drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 40 APAC drug delivery devices market, by region, 2018 - 2030 (USD Billion)
• Table 41 APAC drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 42 APAC drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 43 APAC drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 44 China drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 45 China drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 46 China drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 47 Japan drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 48 Japan drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 49 Japan drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 50 India drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 51 India drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 52 India drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 53 Thailand drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 54 Thailand drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 55 Thailand drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 56 South Korea drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 57 South Korea drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 58 South Korea drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 59 Australia drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 60 Australia drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 61 Australia drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 62 Latin America drug delivery devices market, by region, 2018 - 2030 (USD Billion)
• Table 63 Latin America drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 64 Latin America drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 65 Latin America drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 66 Brazil drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 67 Brazil drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 68 Brazil drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 69 Mexico drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 70 Mexico drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 71 Mexico drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 72 Argentina drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 73 Argentina drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 74 Argentina drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 75 Middle East and Africa drug delivery devices market, by region, 2018 - 2030 (USD Billion)
• Table 76 Middle East and Africa drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 77 Middle East and Africa drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 78 Middle East and Africa drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 79 South Africa drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 80 South Africa drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 81 South Africa drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 82 Saudi Arabia drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 83 Saudi Arabia drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 84 Saudi Arabia drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 85 UAE drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 86 UAE drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 87 UAE drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
• Table 88 Kuwait drug delivery devices market, by RoA, 2018 - 2030 (USD Billion)
• Table 89 Kuwait drug delivery devices market, by application, 2018 - 2030 (USD Billion)
• Table 90 Kuwait drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews in North America
• Fig. 5 Primary interviews in Europe
• Fig. 6 Primary interviews in APAC
• Fig. 7 Primary interviews in Latin America
• Fig. 8 Primary interviews in MEA
• Fig. 9 Market research approaches
• Fig. 10 Value-chain-based sizing & forecasting
• Fig. 11 QFD modeling for market share assessment
• Fig. 12 Market formulation & validation
• Fig. 13 Drug delivery devices: market outlook
• Fig. 14 Drug delivery devices market competitive insights
• Fig. 15 Parent market outlook
• Fig. 16 Related/ancillary market outlook.
• Fig. 17 Penetration and growth prospect mapping
• Fig. 18 Industry value chain analysis
• Fig. 19 Drug delivery devices market driver impact
• Fig. 20 Drug delivery devices market restraint impact
• Fig. 21 Drug delivery devices market strategic initiatives analysis
• Fig. 22 Drug delivery devices market: RoA movement analysis
• Fig. 23 Drug delivery devices market: RoA outlook and key takeaways
• Fig. 24 Oral market estimates and forecast, 2018 - 2030
• Fig. 25 Inhalation market estimates and forecast, 2018 - 2030
• Fig. 26 Transdermal market estimates and forecast, 2018 - 2030
• Fig. 27 Injectable market estimates and forecast, 2018 - 2030
• Fig. 28 Ocular market estimates and forecast, 2018 - 2030
• Fig. 29 Nasal market estimates and forecast, 2018 - 2030
• Fig. 30 Topical market estimates and forecast, 2018 - 2030
• Fig. 31 Others market estimates and forecast, 2018 - 2030
• Fig. 32 Drug delivery devices market: application movement analysis
• Fig. 33 Drug delivery devices market: application outlook and key takeaways
• Fig. 34 Oncology market estimates and forecast, 2018 - 2030
• Fig. 35 Infectious diseases estimates and forecast, 2018 - 2030
• Fig. 36 Respiratory diseases estimates and forecast, 2018 - 2030
• Fig. 37 Diabetes estimates and forecast, 2018 - 2030
• Fig. 38 Cardiovascular diseases estimates and forecast, 2018 - 2030
• Fig. 39 Autoimmune diseases estimates and forecast, 2018 - 2030
• Fig. 40 Central nervous system disorders estimates and forecast, 2018 - 2030
• Fig. 41 Others estimates and forecast, 2018 - 2030
• Fig. 42 Drug delivery devices market: end-use movement analysis
• Fig. 43 Drug delivery devices market: End-use outlook and key takeaways
• Fig. 44 Hospitals estimates and forecast, 2018 - 2030
• Fig. 45 Diagnostic centers estimates and forecast, 2018 - 2030
• Fig. 46 Ambulatory surgery centers/clinics estimates and forecast, 2018 - 2030
• Fig. 47 Home care setting estimates and forecast, 2018 - 2030
• Fig. 48 Others estimates and forecast, 2018 - 2030
• Fig. 49 Global drug delivery devices market: regional movement analysis
• Fig. 50 Global drug delivery market: regional outlook and key takeaways
• Fig. 51 Global market share and leading players
• Fig. 52 North America market share and leading players
• Fig. 53 Europe market share and leading players
• Fig. 54 Asia Pacific market share and leading players
• Fig. 55 Latin America market share and leading players
• Fig. 56 Middle East & Africa market share and leading players
• Fig. 57 North America: SWOT
• Fig. 58 Europe SWOT
• Fig. 59 Asia Pacific SWOT
• Fig. 60 Latin America SWOT
• Fig. 61 MEA SWOT
• Fig. 62 North America, by country
• Fig. 63 North America
• Fig. 64 North America market estimates and forecast, 2018 - 2030
• Fig. 65 U.S.
• Fig. 66 U.S. market estimates and forecast, 2018 - 2030
• Fig. 67 Canada
• Fig. 68 Canada market estimates and forecast, 2018 - 2030
• Fig. 69 Europe
• Fig. 70 Europe. market estimates and forecast, 2018 - 2030
• Fig. 71 UK
• Fig. 72 UK market estimates and forecast, 2018 - 2030
• Fig. 73 Germany
• Fig. 74 Germany market estimates and forecast, 2018 - 2030
• Fig. 75 France
• Fig. 76 France market estimates and forecast, 2018 - 2030
• Fig. 77 Italy
• Fig. 78 Italy market estimates and forecast, 2018 - 2030
• Fig. 79 Spain
• Fig. 80 Spain market estimates and forecast, 2018 - 2030
• Fig. 81 Denmark
• Fig. 82 Denmark market estimates and forecast, 2018 - 2030
• Fig. 83 Sweden
• Fig. 84 Sweden market estimates and forecast, 2018 - 2030
• Fig. 85 Norway
• Fig. 86 Norway market estimates and forecast, 2018 - 2030
• Fig. 87 Asia Pacific
• Fig. 88 Asia Pacific market estimates and forecast, 2018 - 2030
• Fig. 89 China
• Fig. 90 China market estimates and forecast, 2018 - 2030
• Fig. 91 Japan
• Fig. 92 Japan market estimates and forecast, 2018 - 2030
• Fig. 93 India
• Fig. 94 India market estimates and forecast, 2018 - 2030
• Fig. 95 Thailand
• Fig. 96 Thailand. market estimates and forecast, 2018 - 2030
• Fig. 97 South Korea
• Fig. 98 South Korea market estimates and forecast, 2018 - 2030
• Fig. 99 Australia
• Fig. 100 Australia market estimates and forecast, 2018 - 2030
• Fig. 101 Latin America
• Fig. 102 Latin America market estimates and forecast, 2018 - 2030
• Fig. 103 Brazil
• Fig. 104 Brazil market estimates and forecast, 2018 - 2030
• Fig. 105 Mexico
• Fig. 106 Mexico market estimates and forecast, 2018 - 2030
• Fig. 107 Argentina
• Fig. 108 Argentina market estimates and forecast, 2018 - 2030
• Fig. 109 Middle East and Africa
• Fig. 110 Middle East and Africa. market estimates and forecast, 2018 - 2030
• Fig. 111 South Africa
• Fig. 112 South Africa market estimates and forecast, 2018 - 2030
• Fig. 113 Saudi Arabia
• Fig. 114 Saudi Arabia market estimates and forecast, 2018 - 2030
• Fig. 115 UAE
• Fig. 116 UAE market estimates and forecast, 2018 - 2030
• Fig. 117 Kuwait
• Fig. 118 Kuwait market estimates and forecast, 2018 - 2030
• Fig. 119 Participant categorization- drug delivery devices market
• Fig. 120 Market share of key market players- drug delivery devices market

Drug Delivery Devices Market Growth & Trends:

The global drug delivery devices market size is expected to reach USD 403.6 billion by 2030, registering a CAGR of 5.83% during the forecast period, according to a new report by Grand View Research, Inc. Growing prevalence of cancer, neurological disorders, diabetes, and other infectious diseases is expected to drive the adoption of drug delivery devices in the coming years. In addition, increasing product launches for various applications such as ophthalmology, neurology, and oncology are also expected to propel the market growth. Growing adoption of wearable drug delivery devices for its usage in home-care settings is also expected to drive the market.

Hydrogel is one of the prominent drug delivery vehicles and includes supramolecular hydrogels, DNA hydrogels, bio-inspired hydrogels, multi-functional and stimuli-responsive hydrogels. These advanced hydrogels are used for various applications such as ophthalmic, oral, intestinal, cardiac illness, and cancer. Similarly, other vehicles such as liposomes, nanoparticles, and micelle are also being developed for various applications.

Key players present in the market are adopting various strategies such as mergers and acquisitions, partnership, and collaborations to develop and improve drug delivery devices for various applications. Moreover, end-users are also forming partnerships with companies to acquire drug delivery devices for training purpose and research studies. In addition, market players are also forming distribution agreement to expand the reach of their products. Therefore, alliances made by the players are expected to drive the market growth during the forecast period.

Drug Delivery Devices Market Report Highlights:

• The oral route of administration segment held largest share in 2023 mainly due to its easy usage and low cost
• The injectable route of administration segment is expected to experience the fastest growth during the forecast period mainly due to growing advancements in injectable devices for accuracy
• Drug delivery devices for central nervous system disorders are expected to experience fastest growth rate mainly due to growing development of blood brain barrier drug delivery devices for the treatment of neurological disorders
• In 2023, North America dominated the global space with the largest revenue share owing to the adoption of drug delivery devices in the region and increasing product launches in the countries such as U.S.
• Asia Pacific is expected to grow at fastest growth rate during the forecast period mainly due to growing development and advancement in drug delivery devices in the region and presence of large patient pool.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Route of admission (RoA)
  • 1.1.2. Application
  • 1.1.3. End-use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interview in North America
    • 1.3.5.2. Data for primary interview in Europe
    • 1.3.5.3. Data for primary interview in Asia Pacific
    • 1.3.5.4. Data for primary interview in Latin America
    • 1.3.5.5. Data for primary interview in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Route of administration (RoA) outlook
  • 2.2.2. Application outlook
  • 2.2.3. End-use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Drug Delivery Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Industry Value Chain Analysis
  • 3.3.1. Reimbursement framework
• 3.4. Market Dynamics
  • 3.4.1. Market driver analysis
    • 3.4.1.1. Growing demand for novel drug delivery devices
    • 3.4.1.2. Increasing prevalence of chronic diseases
    • 3.4.1.3. Technological advancement in drug delivery devices
    • 3.4.1.4. Growing strategic alliances for drug delivery devices
  • 3.4.2. Market restraint analysis
    • 3.4.2.1. Challenges associated with various routes of drug delivery devices
  • 3.4.3. Industry challenges
• 3.5. Drug Delivery Devices Market Analysis Tools
  • 3.5.1. Industry Analysis - Porter's
    • 3.5.1.1. Supplier power
    • 3.5.1.2. Buyer power
    • 3.5.1.3. Substitution threat
    • 3.5.1.4. Threat of new entrant
    • 3.5.1.5. Competitive rivalry
  • 3.5.2. PESTEL Analysis
    • 3.5.2.1. Political landscape
    • 3.5.2.2. Technological landscape
    • 3.5.2.3. Economic landscape
  • 3.5.3. Major Deals & Strategic Alliances Analysis
  • 3.5.4. Market Entry Strategies

Chapter 4. Route of Administration (RoA) Estimates & Trend Analysis

• 4.1. Definition and Scope
  • 4.1.1. Oral
  • 4.1.2. Inhalation
  • 4.1.3. Transdermal
  • 4.1.4. Injectable
  • 4.1.5. Ocular
  • 4.1.6. Nasal
  • 4.1.7. Topical
  • 4.1.8. Others
• 4.2. RoA Market Share, 2024 & 2030
• 4.3. Segment Dashboard
• 4.4. Global Drug Delivery Devices Market by RoA Outlook
• 4.5. Market Size & Forecast and Trend Analysis, 2018 to 2030 for the following
  • 4.5.1. Oral
    • 4.5.1.1. Market estimates and forecast, by oral, 2018 to 2030 (Revenue, USD Billion)
  • 4.5.2. Inhalation
    • 4.5.2.1. Market estimates and forecast, by inhalation, 2018 to 2030 (Revenue, USD Billion)
  • 4.5.3. Transdermal
    • 4.5.3.1. Market estimates and forecast, by transdermal, 2018 to 2030 (Revenue, USD Billion)
  • 4.5.4. Injectable
    • 4.5.4.1. Market estimates and forecast, by injectable, 2018 to 2030 (Revenue, USD Billion)
  • 4.5.5. Ocular
    • 4.5.5.1. Market estimates and forecast, by ocular, 2018 to 2030 (Revenue, USD Billion)
  • 4.5.6. Nasal
    • 4.5.6.1. Market estimates and forecast, by nasal, 2018 to 2030 (Revenue, USD Billion)
  • 4.5.7. Topical
    • 4.5.7.1. Market estimates and forecast, by tropical, 2018 to 2030 (Revenue, USD Billion)
  • 4.5.8. Others
    • 4.5.8.1. Market estimates and forecast, by others, 2018 to 2030 (Revenue, USD Billion)

Chapter 5. Application Estimates & Trend Analysis

• 5.1. Definition and Scope
  • 5.1.1. Oncology
  • 5.1.2. Infectious diseases
  • 5.1.3. Respiratory disease
  • 5.1.4. Diabetes
  • 5.1.5. Cardiovascular disease
  • 5.1.6. Autoimmune disease
  • 5.1.7. Central nervous system disorders
  • 5.1.8. Others
• 5.2. Application Market Share, 2024 & 2030
• 5.3. Segment Dashboard
• 5.4. Global Drug Delivery Devices Market by Application Outlook
• 5.5. Market Size & Forecast and Trend Analysis, 2018 to 2030 for the following
  • 5.5.1. Oncology
    • 5.5.1.1. Market estimates and forecast, by oncology, 2018 to 2030 (Revenue, USD Billion)
  • 5.5.2. Infectious disease
    • 5.5.2.1. Market estimates and forecast, by infectious disease, 2018 to 2030 (Revenue, USD Billion)
  • 5.5.3. Respiratory disease
    • 5.5.3.1. Market estimates and forecast, by respiratory disease, 2018 to 2030 (Revenue, USD Billion)
  • 5.5.4. Diabetes
    • 5.5.4.1. Market estimates and forecast, by diabetes, 2018 to 2030 (Revenue, USD Billion)
  • 5.5.5. Cardiovascular diseases
    • 5.5.5.1. Market estimates and forecast, by cardiovascular diseases, 2018 to 2030 (Revenue, USD Billion)
  • 5.5.6. Autoimmune disease
    • 5.5.6.1. Market estimates and forecast, by autoimmune disease, 2018 to 2030 (Revenue, USD Billion)
  • 5.5.7. Central nervous system disorders
    • 5.5.7.1. Market estimates and forecast, by central nervous system disorders, 2018 to 2030 (Revenue, USD Billion)
  • 5.5.8. Others
    • 5.5.8.1. Market estimates and forecast, by others, 2018 to 2030 (Revenue, USD Billion)

Chapter 6. End-use Estimates & Trend Analysis

• 6.1. Definition and Scope
  • 6.1.1. Hospitals
  • 6.1.2. Diagnostic centers
  • 6.1.3. Ambulatory surgery centers/clinics
  • 6.1.4. Home care settings
  • 6.1.5. Others
• 6.2. End-use Market Share, 2023 & 2030
• 6.3. Segment Dashboard
• 6.4. Global Drug Delivery Devices Market by End-use Outlook
• 6.5. Market Size & Forecast and Trend Analysis, 2018 to 2030 for the following
  • 6.5.1. Hospital
    • 6.5.1.1. Market estimates and forecast, by hospital, 2018 to 2030 (Revenue, USD Billion)
  • 6.5.2. Diagnostic centers
    • 6.5.2.1. Market estimates and forecast, by diagnostic centers, 2018 to 2030 (Revenue, USD Billion)
  • 6.5.3. Ambulatory surgery centers/clinics
    • 6.5.3.1. Market estimates and forecast, by ambulatory surgery centers/clinics, 2018 to 2030 (Revenue, USD Billion)
  • 6.5.4. Home care settings
    • 6.5.4.1. Market estimates and forecast, by home care settings, 2018 to 2030 (Revenue, USD Billion)
  • 6.5.5. Others
    • 6.5.5.1. Market estimates and forecast, by others, 2018 to 2030 (Revenue, USD Billion)

Chapter 7. Drug Delivery Devices Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2023 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Regional Market Share and Leading Players, 2019
  • 7.4.1. North America
  • 7.4.2. Europe
  • 7.4.3. Asia Pacific
  • 7.4.4. Latin America
  • 7.4.5. Middle East & Africa
• 7.5. SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • 7.5.1. North America
  • 7.5.2. Europe
  • 7.5.3. Asia Pacific
  • 7.5.4. Latin America
  • 7.5.5. Middle East & Africa
• 7.6. Market Size & Forecast, Volume & Trend Analysis, 2018 to 2030
• 7.7. North America
  • 7.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.7.2. U.S.
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Reimbursement structure
    • 7.7.2.5. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.7.3. Canada
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Regulatory framework
    • 7.7.3.4. Reimbursement structure
    • 7.7.3.5. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
• 7.8. Europe
  • 7.8.1. UK
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Competitive scenario
    • 7.8.1.3. Regulatory framework
    • 7.8.1.4. Reimbursement structure
    • 7.8.1.5. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.8.2. Germany
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Competitive scenario
    • 7.8.2.3. Regulatory framework
    • 7.8.2.4. Reimbursement structure
    • 7.8.2.5. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.8.3. France
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Competitive scenario
    • 7.8.3.3. Regulatory framework
    • 7.8.3.4. Reimbursement structure
    • 7.8.3.5. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.8.4. Italy
    • 7.8.4.1. Key country dynamics
    • 7.8.4.2. Competitive scenario
    • 7.8.4.3. Regulatory framework
    • 7.8.4.4. Reimbursement structure
    • 7.8.4.5. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.8.5. Spain
    • 7.8.5.1. Key country dynamics
    • 7.8.5.2. Competitive scenario
    • 7.8.5.3. Regulatory framework
    • 7.8.5.4. Reimbursement structure
    • 7.8.5.5. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.8.6. Denmark
    • 7.8.6.1. Key country dynamics
    • 7.8.6.2. Competitive scenario
    • 7.8.6.3. Regulatory framework
    • 7.8.6.4. Reimbursement structure
    • 7.8.6.5. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.8.7. Sweden
    • 7.8.7.1. Key country dynamics
    • 7.8.7.2. Competitive scenario
    • 7.8.7.3. Regulatory framework
    • 7.8.7.4. Reimbursement structure
    • 7.8.7.5. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.8.8. Norway
    • 7.8.8.1. Key country dynamics
    • 7.8.8.2. Competitive scenario
    • 7.8.8.3. Regulatory framework
    • 7.8.8.4. Reimbursement structure
    • 7.8.8.5. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
• 7.9. Asia Pacific
  • 7.9.1. Japan
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Competitive scenario
    • 7.9.1.3. Regulatory framework
    • 7.9.1.4. Reimbursement structure
    • 7.9.1.5. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.9.2. China
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Competitive scenario
    • 7.9.2.3. Regulatory framework
    • 7.9.2.4. Reimbursement structure
    • 7.9.2.5. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.9.3. India
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Competitive scenario
    • 7.9.3.3. Regulatory framework
    • 7.9.3.4. Reimbursement structure
    • 7.9.3.5. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.9.4. Australia
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Competitive scenario
    • 7.9.4.3. Regulatory framework
    • 7.9.4.4. Reimbursement structure
    • 7.9.4.5. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.9.5. South Korea
    • 7.9.5.1. Key country dynamics
    • 7.9.5.2. Competitive scenario
    • 7.9.5.3. Regulatory framework
    • 7.9.5.4. Reimbursement structure
    • 7.9.5.5. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.9.6. Thailand
    • 7.9.6.1. Key country dynamics
    • 7.9.6.2. Competitive scenario
    • 7.9.6.3. Regulatory framework
    • 7.9.6.4. Reimbursement structure
    • 7.9.6.5. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
• 7.10. Latin America
  • 7.10.1. Brazil
    • 7.10.1.1. Key country dynamics
    • 7.10.1.2. Competitive scenario
    • 7.10.1.3. Regulatory framework
    • 7.10.1.4. Reimbursement structure
    • 7.10.1.5. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.10.2. Mexico
    • 7.10.2.1. Key country dynamics
    • 7.10.2.2. Competitive scenario
    • 7.10.2.3. Regulatory framework
    • 7.10.2.4. Reimbursement structure
    • 7.10.2.5. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.10.3. Argentina
    • 7.10.3.1. Key country dynamics
    • 7.10.3.2. Competitive scenario
    • 7.10.3.3. Regulatory framework
    • 7.10.3.4. Reimbursement structure
    • 7.10.3.5. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
• 7.11. MEA
  • 7.11.1. South Africa
    • 7.11.1.1. Key country dynamics
    • 7.11.1.2. Competitive scenario
    • 7.11.1.3. Regulatory framework
    • 7.11.1.4. Reimbursement structure
    • 7.11.1.5. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.11.2. Saudi Arabia
    • 7.11.2.1. Key country dynamics
    • 7.11.2.2. Competitive scenario
    • 7.11.2.3. Regulatory framework
    • 7.11.2.4. Reimbursement structure
    • 7.11.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.11.3. UAE
    • 7.11.3.1. Key country dynamics
    • 7.11.3.2. Competitive scenario
    • 7.11.3.3. Regulatory framework
    • 7.11.3.4. Reimbursement structure
    • 7.11.3.5. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.11.4. Kuwait
    • 7.11.4.1. Key country dynamics
    • 7.11.4.2. Competitive scenario
    • 7.11.4.3. Regulatory framework
    • 7.11.4.4. Reimbursement structure
    • 7.11.4.5. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
  • 8.2.1. Innovators
  • 8.2.2. Market Lenders
  • 8.2.3. Emerging Players
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2023
• 8.4. Public Companies
  • 8.4.1. Company market position analysis (Revenue, geographic, presence, product portfolio, key serviceable industries, key alliance
  • 8.4.2. Company market share/ranking, by region
  • 8.4.3. Competitive dashboard analysis
    • 8.4.3.1. Market differentiators
    • 8.4.3.2. Synergy analysis: major deals and strategic alliances
• 8.5. Private Companies
  • 8.5.1. List of key emerging companies/technology disruptors/innovators
  • 8.5.2. Funding outlook
  • 8.5.3. Regional network map
  • 8.5.4. Company market position analysis (Geographic, presence, product portfolio, key alliance, industry experience)
• 8.6. Suppliers Ranking
• 8.7. Key Companies Profiled
  • 8.7.1. Pfizer, Inc,
    • 8.7.1.1. Company overview
    • 8.7.1.2. Financial performance
    • 8.7.1.3. Product benchmarking
    • 8.7.1.4. Strategic initiatives
  • 8.7.2. F. Hoffmann-La Roche Ltd.
    • 8.7.2.1. Company overview
    • 8.7.2.2. Financial performance
    • 8.7.2.3. Product benchmarking
    • 8.7.2.4. Strategic initiatives
  • 8.7.3. Johnson and Johnson Services
    • 8.7.3.1. Company overview
    • 8.7.3.2. Financial performance
    • 8.7.3.3. Product benchmarking
    • 8.7.3.4. Strategic initiatives
  • 8.7.4. Novartis AG
    • 8.7.4.1. Company overview
    • 8.7.4.2. Financial performance
    • 8.7.4.3. Product benchmarking
    • 8.7.4.4. Strategic initiatives
  • 8.7.5. Bayer AG
    • 8.7.5.1. Company overview
    • 8.7.5.2. Financial performance
    • 8.7.5.3. Product benchmarking
    • 8.7.5.4. Strategic initiatives
  • 8.7.6. BD
    • 8.7.6.1. Company overview
    • 8.7.6.2. Financial performance
    • 8.7.6.3. Product benchmarking
    • 8.7.6.4. Strategic initiatives
  • 8.7.7. Uniqure N.V.
    • 8.7.7.1. Company overview
    • 8.7.7.2. Financial performance
    • 8.7.7.3. Product benchmarking
    • 8.7.7.4. Strategic initiatives
  • 8.7.8. SiBiono GeneTech Co.
    • 8.7.8.1. Company overview
    • 8.7.8.2. Financial performance
    • 8.7.8.3. Product benchmarking
    • 8.7.8.4. Strategic initiatives
  • 8.7.9. Shanghai Sunway Biotech Co., Ltd
    • 8.7.9.1. Company overview
    • 8.7.9.2. Financial performance
    • 8.7.9.3. Product benchmarking
    • 8.7.9.4. Strategic initiatives
  • 8.7.10. Human Stem Cells Institute
    • 8.7.10.1. Company overview
    • 8.7.10.2. Financial performance
    • 8.7.10.3. Product benchmarking
    • 8.7.10.4. Strategic initiatives